India–New Zealand $20 billion FTA: List of sectors set to gain ground as the deal kicks in

The India–New Zealand Free Trade Agreement, signed on April 27, 2026, is expected to be operationalised within 2026, immediately reshaping bilateral trade fl...

What Happened

The India–New Zealand Free Trade Agreement, signed on April 27, 2026, is expected to be operationalised within 2026, immediately reshaping bilateral trade flows.
Indian exporters in textiles, leather, pharmaceuticals, auto components, gems and jewellery, and processed foods gain immediate zero-duty access to the New Zealand market across 8,000+ tariff lines.
The gems and jewellery sector alone is projected to grow exports to USD 50 million within three years under zero-duty access.
New Zealand is to invest USD 20 billion in India over 15 years across agri-value chains and innovation sectors.
Total bilateral trade — currently USD 2.4 billion (goods and services combined) — is targeted to reach USD 5 billion within five years.
Tariff reductions for New Zealand exports to India are structured on phased timelines: wine tariffs to fall from 150% to 25–50% over 10 years; manuka honey from 66% to 16.5% over 5 years.
The agreement includes dedicated chapters on the digital economy, health and traditional medicine (AYUSH), and professional mobility for Indian workers in IT, healthcare, and engineering in New Zealand.

Static Topic Bridges

India's Labour-Intensive Export Sectors and FTA Leverage

India's comparative advantage in global trade lies heavily in labour-intensive manufacturing — textiles and apparel, leather goods, gems and jewellery, and pharmaceuticals generics. These sectors employ tens of millions of workers, are often located in smaller cities and semi-urban clusters, and are highly sensitive to tariff differentials in destination markets. FTAs that provide zero-duty access give Indian exporters a structural cost advantage over competitors from non-partner countries who face MFN tariffs.

Textiles and apparel: India competes with Bangladesh, Vietnam, and Cambodia; zero-duty NZ access reduces a competitive gap
Pharmaceuticals: India is among the world's largest generic drug exporters; zero-duty access in any market directly boosts margins
Gems and jewellery: India processes over 90% of the world's diamonds by volume; New Zealand's small but affluent market offers premium pricing
Auto components: India's auto component exports exceeded USD 21 billion globally; niche opportunities in NZ's right-hand-drive vehicle market

Connection to this news: The immediate zero-duty access granted to India in the New Zealand FTA provides a competitive edge precisely in the sectors where India has the greatest employment and export depth.

Tariff Engineering and Phased Liberalisation

Phased tariff elimination — where tariffs are reduced gradually over agreed timelines rather than immediately — is a standard FTA tool that allows domestic industries time to adjust to import competition. The pace and depth of phase-down schedules are negotiated based on each sector's sensitivity. "Sensitive lists" or "exclusion lists" protect industries where domestic producers cannot withstand sudden foreign competition (e.g., India's dairy, sugar, and edible oils sectors).

Immediate zero-duty: covers sectors where India has lobbied for quick gains (textiles, pharma)
Phased reduction (5–10 years): used for sectors in New Zealand's interest where India sought adjustment time (wine, honey, some agricultural products)
Exclusion lists: India has maintained exclusions for dairy, sugar, and edible oils in this and other FTAs
"Best access" provisions: New Zealand secured the best tariff rate of any significant kiwi fruit exporter — duty-free quota access plus 50% tariff reduction outside quota

Connection to this news: The asymmetric structure of the FTA — immediate full access for India, phased access for New Zealand in select categories — reflects India's stronger negotiating leverage and its strategic export-promotion priorities.

AYUSH and Health as a Trade Dimension

The FTA includes a first-ever dedicated chapter on health and traditional medicine, formally recognising India's AYUSH (Ayurveda, Yoga, Unani, Siddha, Homeopathy) system in a bilateral trade agreement. This represents a significant normative step — embedding traditional medicine recognition into a trade architecture typically dominated by pharmaceutical and biomedical norms.

AYUSH sector: administered by the Ministry of AYUSH; growing global export potential in herbal products, wellness, and yoga services
Recognition in an FTA creates a framework for regulatory cooperation, product standards, and market access for AYUSH products
Precedent: no prior Indian FTA had explicitly included a traditional medicine chapter

Connection to this news: The inclusion of the AYUSH chapter in the India–New Zealand FTA positions India's traditional medicine sector for structured market access and could set a template for future agreements.

Key Facts & Data

Bilateral goods trade: USD 1.3 billion (2024–25); total goods + services: USD 2.4 billion
FTA target: USD 5 billion bilateral trade within 5 years
New Zealand investment commitment: USD 20 billion in India over 15 years
India tariff lines granted duty-free by New Zealand: 8,000+ (100% of lines)
New Zealand exports receiving tariff cuts: 95% of tariff lines; average India tariff on NZ goods drops to ~3%
Gems & jewellery exports projection: USD 50 million to New Zealand within 3 years (from near-zero)
Wine tariffs: 150% → 25–50% over 10 years
Manuka honey tariffs: 66% → 16.5% over 5 years
India merchandise exports to New Zealand: USD 711 million (2024–25, +32% year-on-year)
Key Indian exports: pharmaceuticals, machinery, textiles, precious stones and metals
Key New Zealand exports to India: wool, iron and steel, fruits and nuts, aluminium
Visas for Indian professionals in IT, healthcare, and engineering in New Zealand included as a services provision